While exploring the mechanistic action of compound, we found that the compound exerts anti-proliferative and anti-invasive activity via interfering with EGF binding to EGFR and inhibition EGFR activation as observed in MDA-MB 231 and primary breast cancer cells. Here, EGFR is linked to breast cancer.